Literature DB >> 32248454

Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.

E V Krutikova1, E A Stepanova2, P F Wong2, I V Kiseleva2, E P Grigor'eva2, L G Rudenko2.   

Abstract

The reassortant vaccine strain of live attenuated influenza vaccine inherits temperature sensitivity and areactogenicity from cold-adapted attenuated master donor virus. In Russia, B/ USSR/60/69 master donor virus (B60) is currently in use for the preparation of live attenuated type B influenza vaccine candidates. Trivalent live attenuated influenza vaccine based on A/ Leningrad/134/17/57 and B60 are licensed for the use in Russia for single dose vaccination of adults and children over 3 years. B/Leningrad/14/17/55 (B14) cold-adapted virus is a backup master donor virus for live attenuated type B influenza vaccine. According to our preliminary estimates, it is more attenuated than B60, which can allow expanding applicability of this vaccine for children under 3 years of age. In this paper, the role of B14 genes in its attenuation was assessed. Representative collection of reassortants of B14 with epidemic influenza B viruses was obtained, a phenotypic analysis of reassortants was performed, and their pathogenicity for animals was assessed. The leading role of PB2 and PA genes in attenuation of B14 master donor virus was proven.

Entities:  

Keywords:  attenuation; influenza В virus; live attenuated influenza vaccine; master donor virus

Mesh:

Substances:

Year:  2020        PMID: 32248454     DOI: 10.1007/s10517-020-04777-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

Review 1.  Antigenic characterization of influenza and SARS-CoV-2 viruses.

Authors:  Yang Wang; Cynthia Y Tang; Xiu-Feng Wan
Journal:  Anal Bioanal Chem       Date:  2021-12-14       Impact factor: 4.142

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.